Norvasc and Application site discoloration - a phase IV clinical study of FDA data
Application site discoloration is reported only by a few people who take Norvasc.
The phase IV clinical study analyzes which people take Norvasc and have Application site discoloration. It is created by eHealthMe based on reports of 128,409 people who have side effects while taking Norvasc from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
128,409 people reported to have side effects when taking Norvasc.
Among them, 5 people (0.0%) have Application site discoloration.
What is Norvasc?
Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 131,555 Norvasc users for its effectiveness, alternative drugs and more.
What is Application site discoloration?
Application site discoloration is found to be associated with 550 drugs and 343 conditions by eHealthMe.
Number of Norvasc and Application site discoloration reports submitted per year:
Gender of people who have Application site discoloration when taking Norvasc *:
- female: 80 %
- male: 20 %
Age of people who have Application site discoloration when taking Norvasc *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 60 %
- 60+: 40 %
Common drugs people take besides Norvasc *:
- Lisinopril: 2 people, 40.00%
- Levemir: 1 person, 20.00%
- Artane: 1 person, 20.00%
- Ativan: 1 person, 20.00%
- Butrans: 1 person, 20.00%
- Estradiol: 1 person, 20.00%
- Furosemide: 1 person, 20.00%
- Imitrex: 1 person, 20.00%
- Lasix: 1 person, 20.00%
- Zecuity: 1 person, 20.00%
Common side effects people have besides Application site discoloration *:
- Application Site Pain: 4 people, 80.00%
- Application Site Pruritus (application site severe itching of the skin): 2 people, 40.00%
- Application Site Irritation: 2 people, 40.00%
- Application Site Scar: 1 person, 20.00%
- Application Site Rash: 1 person, 20.00%
- Application Site Erythema (redness of the skin at application site): 1 person, 20.00%
- Application Site Discomfort: 1 person, 20.00%
- Application Site Burn: 1 person, 20.00%
Common conditions people have *:
- Pain: 2 people, 40.00%
- Rashes (redness): 1 person, 20.00%
- Leg Pain: 1 person, 20.00%
- Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Norvasc and have Application site discoloration?Check whether Application site discoloration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Application site discoloration and when was it recovered:
Expand to all the drugs that have ingredients of amlodipine besylate:
Alternative drugs to, pros and cons of Norvasc:
- Norvasc (131,555 reports)
Common Norvasc side effects:
Browse all side effects of Norvasc:a b c d e f g h i j k l m n o p q r s t u v w x y z
Application site discoloration treatments and more:
- Application site discoloration (3,933 reports)
COVID vaccines that are related to Application site discoloration:
- Application site discoloration in Moderna COVID Vaccine
- Application site discoloration in Pfizer BioNTech Covid Vaccine
- Application site discoloration in Johnson and Johnson Covid Vaccine
Common drugs associated with Application site discoloration:
- Butrans: 411 reports
- Daytrana: 119 reports
- Nicoderm cq: 103 reports
- Picato: 162 reports
- Valchlor: 114 reports
- Zecuity: 741 reports
All the drugs that are associated with Application site discoloration:
- Application site discoloration (550 drugs)
Common conditions associated with Application site discoloration:
- Actinic keratosis: 126 reports
- Headache: 164 reports
- Migraine: 293 reports
- Pain: 266 reports
- Sun-induced skin changes - keratosis: 126 reports
All the conditions that are associated with Application site discoloration:
- Application site discoloration (343 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyrtec and Apremilast drug interaction - a second ago
- Moxifloxacin and Brain Herniation - 2 seconds ago
- Aspirin and Subarachnoid Haemorrhage - 3 seconds ago
- Pemetrexed Disodium and Pantoprazole Sodium drug interaction - 3 seconds ago
- Indomethacin and Clostridium Difficile Colitis - 6 seconds ago
- Chestnut and Consciousness - Decreased - 7 seconds ago
- Xalkori and Haemorrhagic Stroke - 12 seconds ago
- Xyrem and Allergic Sinusitis - 16 seconds ago
- Furosemide and Joint Contracture - 16 seconds ago
- Oncovin and Nerve Injury - 17 seconds ago